Can BHMT variation and low zinc constrain homocysteine clearance?

Betaine-homocysteine S-methyltransferase (BHMT) serves as a vital, folate-independent parallel pathway for regulating systemic homocysteine levels by remethylating it into methionine.

Molecular and catalytic mechanisms

• Zinc-dependent activation: BHMT is a metalloenzyme containing a catalytic zinc ion tetrahedrally coordinated by three active-site cysteines (Cys217, Cys299, and Cys300).
• Ordered binding kinetics: Catalysis follows an ordered mechanism where homocysteine must bind first to the zinc center. This coordination deprotonates the substrate into a highly reactive zinc-thiolate complex, triggering a conformational change that allows the methyl donor betaine to bind and complete the reaction.

Genetic and nutritional constraints

• Genetic variation: The common non-synonymous coding variant rs3733890 (R239Q) alters BHMT's binding affinity for homocysteine, directly limiting catalytic efficiency and clearing capacity.
• Oxidative and zinc-deficient inactivation: Low zinc availability or oxidative stress promotes the oxidation of active-site residues Cys217 and Cys299. This forms an intramolecular disulfide bond that expels the catalytic zinc ion, completely inactivating the enzyme.

Bottom line

• Genetic variations in BHMT (such as rs3733890) impair baseline clearance capacity, while low zinc levels or oxidative stress physically deactivate the enzyme by expelling its catalytic zinc cofactor. Together, these genetic and nutritional stressors constrain this essential backup homocysteine-clearing pathway.